Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD

On December 16, the FDA approved tapinarof (Vtama) cream 1% for individuals with atopic dermatitis aged 2 years and older. The approval followed the conclusion of the ADORING trial program.

John Browning, MD, a pediatric dermatologist and an ADORING trial investigator, spoke with the HCPLive editorial team about the tapinarof approval and its significance.

#Eczema #AtopicDermatitis